Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization

Consecutive adult patients admitted to the hospital with community-acquired pneumonia from January 2000 to September 2003 were included in this prospective observational cohort study. A total of 459 patients, 259 treated with levofloxacin in single drug therapy at a dose of 500 mg once a day and 209...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of antimicrobial agents 2005, Vol.25 (1), p.75-83
Hauptverfasser:	Querol-Ribelles, José Manuel, Tenías, José María, Querol-Borrás, José Manuel, Labrador, Teodoro, Nieto, Angel, González-Granda, Damiana, Martínez, Isidoro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Ceftriaxone Ceftriaxone - administration & dosage Ceftriaxone - therapeutic use Clarithromycin Clarithromycin - administration & dosage Clarithromycin - therapeutic use Cohort Studies Community-Acquired Infections - drug therapy Community-Acquired Infections - microbiology Community-Acquired Infections - mortality Community-acquired pneumonia Drug Therapy, Combination Female Hospitalization Humans Levofloxacin Male Medical sciences Mortality Ofloxacin - administration & dosage Ofloxacin - therapeutic use Pharmacology. Drug treatments Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Pneumonia, Bacterial - mortality Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!